See the DrugPatentWatch profile for quillivant
When Does Quillivant's Patent Expire?
The primary patent for Quillivant XR, a once-daily formulation of methylphenidate, is set to expire in 2027 [1]. This expiration date is crucial for understanding when generic versions of the medication may become available.
What Happens When Quillivant's Patent Expires?
Upon patent expiration, the door opens for generic pharmaceutical companies to seek approval from regulatory bodies, such as the U.S. Food and Drug Administration (FDA), to market their own versions of Quillivant XR [2]. These generic versions are typically bioequivalent to the brand-name drug, meaning they deliver the same amount of active ingredient into the bloodstream over the same period. If approved, generic versions can offer a lower-cost alternative for patients and healthcare systems [3].
How Much Could Generic Quillivant Cost?
While specific pricing for generic Quillivant XR cannot be determined until it is available on the market, generic drugs generally offer significant cost savings compared to their brand-name counterparts. This reduction in price is a primary driver for the development and approval of generic medications [3].
Who Makes Generic Quillivant?
Currently, no generic versions of Quillivant XR are approved or available. The companies that will manufacture generic Quillivant XR will be determined after their respective applications are approved by regulatory agencies following the expiration of the primary patent [2].
What Are the Alternatives to Quillivant XR?
For individuals seeking treatment for ADHD, several alternative stimulant and non-stimulant medications are available. These include other methylphenidate formulations (both immediate-release and extended-release), amphetamine-based stimulants, and non-stimulant options like atomoxetine [4].
What Are the Risks of Taking Quillivant XR?
Common side effects associated with Quillivant XR, like other methylphenidate medications, can include decreased appetite, sleep difficulties, headache, stomach ache, and irritability. Serious side effects, though less common, can include cardiovascular problems, psychiatric symptoms, and slowed growth in children [5].
How Does Quillivant XR Work?
Quillivant XR is a central nervous system stimulant. It works by increasing the levels of certain neurotransmitters, primarily dopamine and norepinephrine, in the brain. These neurotransmitters play a role in attention, focus, and impulse control, and their modulation helps to manage the symptoms of ADHD [1][5].
Where Can I Find More Information on Drug Patents?
For comprehensive details on drug patents, including expiration dates and patent challenges, resources like DrugPatentWatch.com can provide valuable information [1].
---
Sources
1. DrugPatentWatch.com
2. U.S. Food and Drug Administration (FDA) [Information on generic drugs]
3. Generic Drug Facts
4. National Institute of Mental Health (NIMH) - ADHD Medications
5. Prescribing Information for Quillivant XR